Mary Kay Fenton
2017 - Achillion Pharmaceuticals
In 2017, Mary Kay Fenton earned a total compensation of $991.9K as Former Executive Vice President, Chief Financial Officer and Treasurer at Achillion Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,218 |
|---|---|
| Option Awards | $481,043 |
| Salary | $382,130 |
| Other | $8,557 |
| Total | $991,948 |
Fenton received $481K in option awards, accounting for 48% of the total pay in 2017.
Fenton also received $120.2K in non-equity incentive plan, $382.1K in salary and $8.6K in other compensation.
Rankings
In 2017, Mary Kay Fenton's compensation ranked 9,021st out of 14,666 executives tracked by ExecPay. In other words, Fenton earned more than 38.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,021 out of 14,666 | 39th |
Division Manufacturing | 3,449 out of 5,768 | 40th |
Major group Chemicals And Allied Products | 1,180 out of 2,074 | 43rd |
Industry group Drugs | 944 out of 1,730 | 45th |
Industry Pharmaceutical Preparations | 738 out of 1,329 | 45th |
Source: SEC filing on April 15, 2019.
Fenton's colleagues
We found two more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2017.